Paper36911801
Metabolic Challenges in Anticancer CD8 T Cell Functions.
Amitrano AM and 1 other. Immune Netw, 2023. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolic Challenges in Anticancer CD8 T Cell Functions. Papers, record 36911801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911801
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AI102851 | NIAID NIH HHS | United States | P01AI102851 | PubMed and NIH | NIH RePORTER |
| R01 AI147362 | NIAID NIH HHS | United States | R01AI147362 | PubMed and NIH | NIH RePORTER |
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,529,460 | Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12529460 | PubMed |
| 2 | 34,272,515 | Cancer metabolism: looking forward. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34272515 | PubMed |
| 3 | 33,398,183 | Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33398183 | PubMed |
| 4 | 3,909,197 | Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. | Q J Exp Physiol | 1985 | https://conductscience.org/library/papers/3909197 | PubMed |
| 5 | 30,804,938 | CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. | Front Immunol | 2019 | https://conductscience.org/library/papers/30804938 | PubMed |
| 6 | 15,931,392 | Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15931392 | PubMed |
| 7 | 26,674,251 | Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. | Cell Metab | 2016 | https://conductscience.org/library/papers/26674251 | PubMed |
| 8 | 33,320,840 | Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33320840 | PubMed |
| 9 | 26,321,679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 10 | 34,216,540 | Polyamine metabolism is a central determinant of helper T cell lineage fidelity. | Cell | 2021 | https://conductscience.org/library/papers/34216540 | PubMed |
| 11 | 27,825,556 | Metabolic pathways in T cell activation and lineage differentiation. | Semin Immunol | 2016 | https://conductscience.org/library/papers/27825556 | PubMed |
| 12 | 32,735,779 | Engineering CAR-T Cells for Next-Generation Cancer Therapy. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32735779 | PubMed |
| 13 | 27,745,970 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. | Cell | 2016 | https://conductscience.org/library/papers/27745970 | PubMed |
| 14 | 31,076,448 | Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. | Blood | 2019 | https://conductscience.org/library/papers/31076448 | PubMed |
| 15 | 25,437,876 | Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25437876 | PubMed |
| 16 | 35,504,291 | Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. | Cell Metab | 2022 | https://conductscience.org/library/papers/35504291 | PubMed |
| 17 | 22,990,888 | Metabolic checkpoints in activated T cells. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22990888 | PubMed |
| 18 | 27,836,431 | Constitutive Glycolytic Metabolism Supports CD8+ T Cell Effector Memory Differentiation during Viral Infection. | Immunity | 2016 | https://conductscience.org/library/papers/27836431 | PubMed |
| 19 | 19,543,266 | mTOR regulates memory CD8 T-cell differentiation. | Nature | 2009 | https://conductscience.org/library/papers/19543266 | PubMed |
| 20 | 22,206,904 | Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. | Immunity | 2012 | https://conductscience.org/library/papers/22206904 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,950,055 | Glucose restriction induced by intermittent fasting promotes alternative metabolic fluxes leading to memory CD8+ T cell development. | Sci Adv | 2026 | https://conductscience.org/library/papers/42950055 | PubMed |
| 42,174,730 | CD155 and its receptors in glioma: prospects for emerging immune checkpoint inhibitors. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42174730 | PubMed |
| 42,058,597 | Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42058597 | PubMed |
| 41,860,665 | Exploring the role of metabolic disorders and gut microbiome in immune checkpoint regulation in cancer: PI3K/AKT/mTOR focus. | J Physiol Biochem | 2026 | https://conductscience.org/library/papers/41860665 | PubMed |
| 41,800,028 | Integrating Three Functional Subsets of T Cell Immunity Into an Integrative Model for Cancer Immunotherapy. | Immune Netw | 2026 | https://conductscience.org/library/papers/41800028 | PubMed |
| 41,694,372 | Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694372 | PubMed |
| 40,963,600 | A machine learning-derived immune-related prognostic model identifies PLXNA3 as a functional risk gene in colorectal cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40963600 | PubMed |
| 40,859,981 | CD2-CD58 axis orchestrates cytotoxic T lymphocyte function and metabolic crosstalk in breast cancer brain metastasis. | J Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40859981 | PubMed |
| 40,536,597 | Role of mitochondria in physiological activities, diseases, and therapy. | Mol Biomed | 2025 | https://conductscience.org/library/papers/40536597 | PubMed |
| 40,078,783 | Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment? | Immune Netw | 2025 | https://conductscience.org/library/papers/40078783 | PubMed |
| 40,051,496 | Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/40051496 | PubMed |
| 39,778,404 | Control of T-cell immunity by fatty acid metabolism. | Ann Pediatr Endocrinol Metab | 2024 | https://conductscience.org/library/papers/39778404 | PubMed |
| 38,919,017 | Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy. | BMB Rep | 2024 | https://conductscience.org/library/papers/38919017 | PubMed |
| 38,509,982 | Low expression of lysosome-related genes KCNE1, NPC2, and SFTPD promote cancer cell proliferation and tumor associated M2 macrophage polarization in lung adenocarcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/38509982 | PubMed |
| 36,911,804 | Back to the T Cell: Basic and Clinical Application. | Immune Netw | 2023 | https://conductscience.org/library/papers/36911804 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911801
GET https://conductscience.org/api/papers/v1/36911801/references?page=2